Skip to main content
Signal8

Siegel Jolie

SEC insider (Form 3/4/5 filer). CIK 0001768223. Officer at Odyssey Therapeutics, Inc. (ODTX) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 14, 2025. Located in WATERTOWN, MA.

Companies Siegel Jolie has filed insider reports for

  • Odyssey Therapeutics, Inc. (ODTX): Officer, See Remarks
  • C4 Therapeutics, Inc. (CCCC): Officer, Chief Legal Officer
Siegel Jolie profile photo

Siegel Jolie

CIK: 0001768223

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (57.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Odyssey Therapeutics, Inc. logo
ODTX

Odyssey Therapeutics, Inc.

Officer
C4 Therapeutics, Inc. logo
CCCC

C4 Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Feb 14, 2025
    Tax Payment
    Direct
    2.9K shares at avg. $3.18$9K
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Feb 14, 2025
    Award
    Direct
    56.5K shares-
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Feb 13, 2025
    Tax Payment
    Direct
    2.1K shares at avg. $3.20$7K
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Nov 7, 2024
    Exercise
    Direct
    3.8K shares-
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Nov 7, 2024
    Tax Payment
    Direct
    1.1K shares at avg. $6.04$7K
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Sep 16, 2024
    Exercise
    Direct
    2.3K shares-
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Sep 16, 2024
    Tax Payment
    Direct
    661 shares at avg. $6.36$4K

1-7 of 7